Retatrutide
Select Amount
Total
₹2,399
About Retatrutide
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist under active research investigation. Unlike dual agonists, it simultaneously activates three distinct metabolic receptors, making it a compelling subject for studies in obesity, metabolic syndrome, and cardiovascular risk reduction. Early-phase research has demonstrated significant effects on adipose tissue and insulin sensitivity.
Usage Guidelines
✓ Suitable For
- Metabolic syndrome and obesity mechanism research
- Studies on triple receptor agonism pharmacodynamics
- Cardiovascular metabolic risk biomarker research
- Comparative efficacy research vs. GLP-1 single agonists
✗ Not Recommended For
- Requires controlled cold-chain storage at all times
- Not to be used without proper containment protocols